Announcements Trials

Browse Landscape

Phase

Status

Completed 2 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 2 Motor Activity 2 Lung Neoplasms 2 Breast Neoplasms 2 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Kidney Neoplasms 1 Disease 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Magnetic Resonance Spectroscopy 51 Specimen Handling 42 enzalutamide 35 Androgen Antagonists 34 Radiosurgery 32 Radiotherapy 31 Prednisone 26 darolutamide 24 Abiraterone Acetate 24 Leuprolide 22 Docetaxel 22 apalutamide 20 Pluvicto 19 abiraterone 18 Standard of Care 18 Triptorelin Pamoate 17 Radiation 17 Biopsy 16 relugolix 15 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 15 Goserelin 14 Blood Specimen Collection 13 gallium 68 PSMA-11 12 pembrolizumab 11 X-Rays 11 Surveys and Questionnaires 11 luprolide acetate gel depot 10 Carboplatin 10 Methods 9 Interviews as Topic 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Prostatic Neoplasms × Preoperative Exercise × Clear all

NCT07162987 2025-09-09

PREPP

Odense University Hospital

Phase NA Recruiting

Disease, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡